Insiders · Profile

McIlwain Matthew S

Director at Nautilus Biotechnology. Filing since 24 Aug 2021. CIK 0001381752

Company
Date
Role
Action
Shares
Amount
Of holding
15 Nov 2021
Director
Bought
100,000
$529.89K
27.8%
26 Aug 2021
Director
Bought
11,709
$90.31K
3.4%
25 Aug 2021
Director
Bought
11,693
$90.46K
3.5%
24 Aug 2021
Director
Bought
13,568
$104.27K
4.2%
4 decisions on file.